Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03312686 · ClinicalTrials.gov registry record

Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study

A clinical trial of Eosinophilic Esophagitis, sponsored by Indiana University.

Recruiting
Registry status
10
Enrollment target
2
Study locations

NCT03312686: Recruiting study of Eosinophilic Esophagitis, sponsored by Indiana University.

NCT03312686 is a study of Eosinophilic Esophagitis that is actively recruiting participants, run by Indiana University. The registered enrollment target is 10 participants, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (99% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03312686, a study of Eosinophilic Esophagitis, is actively recruiting participants, sponsored by Indiana University.

RECRUITING
Registry status
10 participants
Enrollment target
2
Study locations

Study Summary

This pilot study will explore whether treatment of eosinophilic inflammation in the esophagus is associated with an improved distensibility of the esophagus. Furthermore, previous studies of the esophagus using EndoFlip only measured distensibility of the distal esophagus, specifically the distal esophagus and esophagogastric junction. Eosinophilia in EoE has been demonstrated to affect both upper, middle and lower esophagus. The aim is to measure distensibility both proximal and distal, before and after treatment.

Primary Outcome

1\. Measure the changes in esophageal distensibility before and after treatment with PPI in patients with esophageal eosinophilia

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST endoflip

Study Locations (2)

Indiana

  • Indiana University Health University Hospital - Indianapolis
  • Indiana University - Indianapolis

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2016-11
Est. Completion 2026-12-31
Indiana University

890 total trials

What NCT03312686 shows while recruiting

NCT03312686 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 864-participant average among 44 other Eosinophilic Esophagitis trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Eosinophilic Esophagitis appearing as the primary indexed condition, and to 1 intervention - of which endoflip is the first listed.

NCT03312686 reports a single indexed study location in Indiana.

Frequently Asked Questions

What is clinical trial NCT03312686 about?

NCT03312686 is a clinical study titled "Changes in Esophageal Distensibility With Proton Pump Inhibitors in Patients With Esophageal Eosinophilia: A Pilot Study". This pilot study will explore whether treatment of eosinophilic inflammation in the esophagus is associated with an improved distensibility of the esophagus. Furthermore, previous studies of the esophagus using EndoFlip only measured distensibility of the distal esophagus, specifically the distal es...

What is the current status of trial NCT03312686?

This trial is currently recruiting. The enrollment target is 10 participants. The study started on 2016-11. Estimated completion is 2026-12-31.

What conditions does trial NCT03312686 study?

This clinical trial studies the following conditions: Eosinophilic Esophagitis.

What interventions are being tested in trial NCT03312686?

The interventions under investigation include: endoflip (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT03312686?

This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03312686 being conducted?

This trial has 2 study locations across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Eosinophilic Esophagitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03312686's enrollment target sits among peer trials

10 43rd of 44 higher than 2 of 44 other Eosinophilic Esophagitis trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Eosinophilic Esophagitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03312686, the US trial registry maintained by the National Library of Medicine. NCT03312686 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.